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Detection of Lipids and Proteins on Biological Surfaces using  
Imaging Mass Spectrometry 
 
Louise Carlred 
Department of Physics 
CHALMERS UNIVERSITY OF TECHNOLOGY 
ABSTRACT 
 
Time-of-flight secondary ion mass spectrometry (ToF-SIMS) is a technique that can be used 
for imaging the spatial distribution of many different molecules at the same time. It is very 
sensitive for detection of small biomolecules, such as lipids, whereas larger biomolecules, 
such as peptides and proteins, cannot be detected as intact entities due to fragmentation. In 
this work, we have explored an alternative approach for detection of peptides and proteins 
with ToF-SIMS, using liposomes for labeling the target of interest. In this way, both lipids 
and proteins can be imaged at the same time, which opens up for the opportunity to 
investigate lipid-protein interactions.  
 
The method has been applied for detection of biomolecules on two different biological 
surfaces; (1) a model surface containing controlled concentrations of target biomolecules 
bound to the substrate and (2) brain tissue sections from Alzheimer’s disease transgenic mice. 
Other techniques, such as fluorescence microscopy and quartz crystal microbalance with 
dissipation monitoring (QCM-D), have also been used for the characterization of liposomes 
binding to the surface. Another imaging mass spectrometry technique, matrix-assisted laser 
desorption/ionization (MALDI), was also employed on mouse brain tissue sections for 
detection and investigation of amyloid-β deposits, a peptide associated with Alzheimer’s 
disease.  
 
This thesis thus shows how different techniques can be combined for investigation of 
biomolecules on complex biological surfaces, in order to potentially provide new information 
about the mechanism of neurodegeneration in Alzheimer’s disease. 
 
Keywords: Imaging Mass Spectrometry, ToF-SIMS, MALDI, QCM-D, Alzheimer’s disease, 
Amyloid-β, phospholipids, cholesterol, sulfatides, GM1  
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1. INTRODUCTION 
 
The plasma membrane constitutes the protective barrier that surrounds all cells in the human 
body (Alberts 2002; Siegel and Ebrary 2006). The major components of the plasma 
membrane are lipids, which due to their hydrophobic and hydrophilic regions form a self-
assembled bilayer that provides an efficient shield against the surrounding aqueous 
environment. In addition to their structural and protective function in the plasma membrane, 
lipids are highly involved in other processes in the cell, such as regulating intracellular 
trafficking (Lippincott-Schwartz and Phair 2010) and participating in cellular signaling, which 
controls cell growth, migration and death (Wenk 2005). 
Other important components in the cell membrane are membrane proteins (Alberts 2002). The 
membrane proteins are involved in a variety of cellular functions, such as communication of 
the cell with the environment, participation in catalytic processes, and transportation of 
substances in or out of the cell. Activation of a membrane protein, usually through ligand 
binding, can result in a signaling cascade within the cell, which is also why the majority of all 
drugs today target the membrane proteins (Arinaminpathy 2009).  
However, it is often not the lipids or proteins per se that are responsible for the signaling 
events in the cell. Recent research has shown that interactions between lipids and proteins in 
the cell membrane highly affects the signaling activity, for example by creating specific 
microenvironments in the lipid bilayer called lipid rafts (Simons and Toomre 2000). These 
rafts have different properties depending on their lipid and protein content, and also 
depending on other proteins or ligands attached to the raft-associated protein (Sheets et al. 
1999). Most lipid rafts consist mainly of sphingolipids and cholesterol, and tend to form 
distinct liquid-ordered phases within the lipid bilayer due to the long and saturated fatty acid 
chains of the sphingolipids in combination with the hydrophobicity and rigidity of cholesterol. 
Cholesterol, in particular, has been found to influence the existence and activity of lipid rafts 
(Pralle et al. 2000).    
Dysregulation of lipids in the cell can result in the generation of various diseases, for example 
by disrupting or promoting particular processes in the plasma membrane, many of which 
depend on lipid-protein interactions. One example is Alzheimer’s disease (AD), for which it 
has been suggested that association of different lipid rafts in the plasma membrane is 
important for the formation of amyloid-β (Aβ) peptides, whose aggregation into so called 
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senile plaques is considered to be one of the main hallmarks of AD (Ehehalt 2003). In 
particular, it has been found that cholesterol is involved in the Aβ aggregation process (Di 
Paolo and Kim 2011; Puglielli et al. 2003). However, it is not known exactly how these 
processes occur or why the balance is disrupted. It is therefore important to study these 
interactions more thoroughly. Many different methods exist that can be used to study proteins 
or lipids separately, however, very few can study these molecules at the same time, which is 
vital for investigation of the interactions between lipids and proteins.  
The aim of this thesis was to develop a new method for simultaneous imaging of both lipids 
and proteins by combining methods traditionally used in immunohistochemistry (IHC) with 
imaging mass spectrometry (IMS). The method has been applied to detect Aβ deposits and 
surrounding distributions of several lipids in transgenic AD mouse brains using time-of-flight 
secondary ion mass spectrometry (ToF-SIMS). Furthermore, the potential for simultaneous 
detection of many different biomolecules, so called multiplexing, was demonstrated on model 
surfaces, by quantitative detection of two different targets, namely the vitamin biotin and the 
glycosphingolipid GM1. The mouse brains were also investigated with matrix-assisted laser 
desorption/ionization (MALDI), for more thorough characterization of the Aβ deposits. 
Together, this work demonstrates the compatibility and complementarity of different methods 
for investigation of the complex biomolecular processes involved in AD.  
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2.  BACKGROUND 
 
2.1 ALZHEIMER’S DISEASE 
AD is the most common form of dementia, which affects nearly 50 millions of people around 
the world (Ballard et al. 2011; M. Prince 2015). The most common symptoms of AD are loss 
of memory and cognitive function, resulting in decreased ability to handle simple tasks (St 
George-Hyslop 2000). The main reason for the development of AD is degeneration of nerve 
cells in the brain, especially in the hippocampus and cortex regions, which are the regions of 
learning and memory. But the reason for this neurodegeneration is not yet completely 
understood.  
One of the main diagnostic features of AD is the accumulation of senile plaques between 
nerve cells in the brain, consisting of aggregates of the peptide Aβ. Another diagnostic 
hallmark of AD is the formation of neurofibrillary tangles (NFT) inside the nerve cells, 
consisting of aggregates of a protein called Tau. The formation of these plaques and tangles 
seems to be connected with the degeneration of nerve cells, but it is not clear how or why the 
aggregation of these molecules occur. Even though there is a clear connection between the 
extent of NFT and the severity of dementia (Arriagada et al. 1992), this pathology is not 
unique for AD, but a common feature for many types of dementia (Ballatore et al. 2007). In 
contrast, there is no clear correlation between the extent of Aβ plaques and the severity of the 
dementia (Terry et al. 1991), suggesting that there are more components involved in the 
neurodegenerative processes in AD. One hypothesis is that the generation of Aβ plaques is a 
less toxic and final product of the degenerative process, whereas the soluble oligomeric forms 
of Aβ peptides, which are precursors to the formation of the plaques, have the most toxic 
properties, by interfering with the synapses that connect the nerve cells during signal 
transduction (Gouras et al. 2015; Selkoe 2008; Walsh and Selkoe 2007). Furthermore, it has 
been found that these soluble, pre-fibrillar Aβ peptides accumulate inside the nerve cells, in 
endosomal vesicles and in the synaptic compartments, at early stages of AD, before 
extracellular Aβ deposition is detectable (Gouras et al. 2013).  
The Aβ peptide is formed through two sequential cleavages of the Amyloid-β precursor 
protein (APP); the catalytic transmembrane proteins β-site APP cleavage enzyme 1 (BACE1), 
also referred to as β-secretase 1, which cleaves APP at the amino-terminal region of the Aβ 
sequence, followed by  multiple actions of the γ-secretase complex, which consists of two 
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proteins derived from the presenilin (PS) 1 and 2 genes (LaFerla 2002; Siegel and Ebrary 
2006). Genetic mutations on APP or PS1/2 are the most common causes of familial AD, 
which often results in early-onset AD (< 65 years). These mutations often result in either 
enhanced production of Aβ peptides, as in the case of the Swedish double mutation (APPswe) 
(Citron et al. 1992), or enhanced production of the specific version of Aβ with 42 amino acids 
(Aβ42), which is the longer and more aggregation-prone Aβ peptide, compared to the Aβ40 
peptide. However, only about 5% of all incidences of AD have been found to be caused by 
genetic mutations (Ballard et al. 2011). Thus, the majority of AD incidences is referred to as 
the sporadic form of AD, and has usually a late-onset age (> 65 years). 
The currently known main risk factor for sporadic AD is, besides from ageing, the possession 
of a specific allele, ε4, of a gene that codes for a protein called apolipoprotein E (ApoE) 
(Siegel and Ebrary 2006). ApoE is involved in the dynamic regulation of lipids, and in 
particular the transportation of cholesterol, in the brain. Cholesterol is an important 
component of the plasma membrane and the myelin sheath that surround the axons of the 
nerve cells. Recent research has shown that dysregulation of cholesterol is involved in the 
generation of different neurodegenerative diseases, including AD (Di Paolo and Kim 2011; 
Puglielli et al. 2003). Especially, the transportation of cholesterol into the cells seems to be 
closely connected to the formation of Aβ peptides, as well as the aggregation of Aβ into toxic 
oligomers and fibrils. Also, cholesterol has been found to regulate the activity of APP 
cleavage into Aβ, by merging β- and γ-secretases into APP containing lipid rafts that are 
present in the cell membrane (Ehehalt 2003). Furthermore, ApoE has been shown to directly 
bind to Aβ and promote the aggregation or clearance of Aβ, possibly in an isoform dose-
dependent manner, where the ε4 allele seems to promote Aβ aggregation while the ε2 allele 
have a more protective function, by promoting clearance of Aβ (Kim et al. 2009). 
Many other lipids have been found to be involved in the generation of Aβ and AD, such as 
ceramides, sphingomyelin and glycosphingolipids (Di Paolo and Kim 2011). In particular, the 
glycosphingolipid GM1 has been found to bind to Aβ and promote the aggregation into Aβ 
fibrils by acting as a seed, especially in combination with increased levels of cholesterol in the 
cell membrane (Kakio et al. 2001; Yanagisawa 2007). Other studies have shown that the 
ceramide levels are highly increased in brain tissue from subjects with mild cognitive 
impairment (MCI), an early stage of AD, at the same time as the sulfatide levels are depleted, 
which further indicates that dysregulation of lipids is an important factor in AD (Han 2010). 
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However, more research is needed to understand how these different components are 
connected. 
Unfortunately, there are no treatments available today that can cure AD. Most prescribed 
drugs alleviate some of the symptoms at the early stages of the disease. One type of 
commonly prescribed drugs for this purpose is cholinesterase inhibitors, which prolong the 
signaling between cholinergic neurons by preventing the degradation of the neurotransmitter 
acetylcholine that is released into the synapse (St George-Hyslop 2000). Other commonly 
prescribed drugs are antipsychotics and antidepressants, which have been shown to have 
limited benefits (Ballard et al. 2011). However, many other treatments are under investigation 
and some of them have reached phase 3 in clinical trials. One approach that seems promising 
is immunotherapy, which involves the use of antibodies to target and promote clearance of Aβ 
in the brain. Earlier studies have shown that the injection of antibodies decreased Aβ 
deposition and improved cognitive behavior in transgenic mouse models (Thakker et al. 
2009). However, clinical trials with AD patients have shown mixed results (Ballard et al. 
2011).  
Another interesting approach for targeting Aβ is to prevent the formation of new Aβ peptides, 
using β- or γ-secretase inhibitors. Several drugs for this purpose have reached phase 3 in 
clinical trials, although none have yet succeeded further. One problem with inhibiting the γ-
secretases is that these enzymes also modulate the activity of other important proteins in the 
cell (Gouras et al. 2015). Other interesting therapies include intake of natural products such as 
Vitamin E, omega 3 fatty acids and in particular the fatty acid docosahexaenoic acid (DHA), 
which is under investigation in phase 3 clinical trials. Other potential drugs include 
modulation or stabilization of Tau aggregates, which have shown some promising results in 
early-phase clinical trials (Ballatore et al. 2007).  
Another type of drugs extensively evaluated as potential candidates for the treatment or 
prevention of AD is the cholesterol-lowering drugs statins. Statins inhibit the endogenous 
production of cholesterol in the cells, and have been used for many years by people with 
elevated blood cholesterol levels, in order to prevent cardiovascular disease. Since the link 
between cholesterol dysregulation and AD was discovered, statins were suggested as a 
potential treatment. Many epidemiological and clinical studies have tried to evaluate the 
benefit of statins in AD prevalence and their effect on cognitive function, although with 
mixed results (Barone et al. 2014). Even though some of the epidemiological studies did show 
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a protective effect and reduced risk of developing AD, several randomized phase 3 clinical 
trials have shown no benefit of statins on cognitive function.  
One of the reasons why many drugs fail, or appear ineffective, in the clinical trials might be 
that the disease progression has already gone too far when the symptoms start to appear. 
Improved diagnosis of AD and earlier treatment would therefore be of great benefit. In fact, 
there are no techniques today that can definitely diagnose AD, or distinguish it from other 
types of dementia, until post mortem analysis. Instead, a probable diagnosis is being made 
based on several different criteria, which are derived through neuropsychological assessment 
in combination with a neuropathological indication, such as apparent brain atrophy in specific 
brain regions, as revealed by structural magnetic resonance imaging (MRI) scans, or 
aberrations in levels of Aβ42 or Tau in the cerebrospinal fluid (CSF) (Ballard et al. 2011).  
Another newly developed technique that can be used for AD diagnosis in vivo is positron 
emission tomography (PET). By using specific markers, such as 18F-fluorodeoxyglucose, PET 
imaging can detect decreased glucose metabolism, which is an indication of AD. Furthermore, 
by using the 11C-labeled Pittsburgh compound B, which binds to Aβ oligomers, it can reveal 
increased amyloid load in the brain. Recently, a study investigated the distribution of Tau 
pathology in the brain using PET imaging with a specific marker for Tau (18F-AV-1451) 
(Schöll et al. 2016). The study was able to distinguish AD disease progression by visualizing 
the distribution of Tau in combination with increased amyloid burden in specific brain regions 
in AD patients, compared to non-demented elderly subjects. Further investigations of these 
promising techniques and the discovery of other AD-specific biomarkers, in the CSF 
(Zetterberg et al. 2010) and in the blood (Thambisetty and Lovestone 2010), increases the 
possibility to detect and treat AD before significant damage occurs in the brain. 
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2.2 IMAGING OF LIPIDS AND PROTEINS IN TISSUE SECTIONS 
Immunohistochemistry 
A general method for investigating the pathological mechanisms of diseases is to image tissue 
sections with optical microscopy (Swedlow 2012). Often different kinds of stains are used as 
markers of specific cell features, such as cell nuclei or protein aggregates (Fig. 1A). This 
method was used already a century ago, when Dr. Alois Alzheimer first discovered the 
pathological hallmarks of AD by investigating brain tissue from a patient with severe 
dementia (Cipriani et al. 2011).  
To be able to target and visualize a specific protein in tissue samples, immunohistochemistry 
(IHC) can be applied. In IHC, specific antibodies are used that recognize the molecule of 
interest. These antibodies can be directly conjugated with a fluorophore, for detection with 
fluorescence microscopy. However, in order to amplify the signal, a subsequent secondary 
antibody labeled with the fluorophore is often used (Fig. 1B). While the so called primary 
antibody usually recognizes a very specific part of the target molecule, called the epitope, the 
secondary antibodies are usually designed so that they recognize many different epitopes on 
the primary antibody, thereby enabling the binding of several secondary antibodies to each 
primary antibody, resulting in amplification of the fluorescence signal. In this way, very low 
concentrations of the target molecules can be localized in the sample. Furthermore, several 
different targets can be localized in the tissue at the same time using different antibodies 
labeled with fluorophores with spectrally distinct fluorescence properties (Jensen 2014).  
However, IHC is limited to the availability of antibodies to the target of interest, and many 
antibodies today are hampered by specificity problems (O’Hurley et al. 2014). Also, the 
selection of secondary antibodies must be done carefully to avoid cross-reactivity and to avoid 
spectral overlap of the fluorophores for specific detection of each target (Lichtman and 
Conchello 2005). Therefore, only 3-4 different targets can normally be imaged at the same 
time when using standard microscopes, although, using a combination of a very sensitive 
imaging spectrometer with appropriate dyes, designed filter sets, and a signal isolation 
algorithm, up to seven different fluorophores have been detected at the same time in a tissue 
section (Tsurui et al. 2000). However, even if antibodies are good for targeting for example 
proteins, many other molecules, such as individual lipids, are lacking a specific epitope that 
can be targeted by an antibody, and can thus not be detected with this method. This, in turn, 
complicates co-localization analysis and investigation of possible interactions between lipids 
and proteins.  
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Figure 1 (A) Optical (bright field) image of the hippocampal region (CA1) of a transgenic AD mouse brain 
stained with eosin methylene blue, showing major tissue structures such as cell nuclei (blue) and the white 
matter of corpus callosum (red). (B) Schematic illustration of the principles of IHC by binding of primary 
antibodies (blue) to the protein of interest (red) followed by secondary antibodies (green) with fluorescent tags 
(yellow). (C-D) Fluorescence images of the hippocampal region (CA1) in two adjacent tissue sections from a 
transgenic AD mouse brain showing (C) Aβ plaques (red), stained with primary (6E10) + secondary (Alexa 555 
goat anti-mouse) antibodies, and (D) NFT (red), stained with primary (AT8) + secondary (Alexa 555 goat anti-
mouse) antibodies. Surrounding cell nuclei is counterstained with DAPI (blue). Scale bar = 200 µm. 
Imaging mass spectrometry 
Imaging mass spectrometry (IMS) is a methodology that can be used for imaging of both 
lipids and proteins in biological samples (Chughtai and Heeren 2010; Pol et al. 2010; Touboul 
et al. 2011). One of the most common IMS techniques is matrix-assisted laser 
desorption/ionization (MALDI), in which a laser is used to produce ions specific to the 
molecules at the surface of the sample. To prevent fragmentation of the analytes during the 
laser-induced desorption and to enhance the ionization probability, the tissue sample is prior 
to analysis sprayed with an organic compound, a so called matrix, which covers the surface of 
the sample. The ions produced by the laser are then separated by a mass analyzer and detected 
to produce a mass spectrum, in which the mass-to-charge ratios (m/z) of the individual peaks 
are used for identification of the detected ions and molecules. In this way, intact molecules up 
to ~100 kDa in mass can be identified and detected on the surface. One disadvantage of 
MALDI is that the matrix can interfere with the detection of small molecules that are in the 
same mass range as the matrix compounds (usually <500 Da, depending on the matrix), 
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thereby excluding the detection of small lipids such as cholesterol (m/z = 369-385). Also, 
different matrices are often needed for detection of different types of molecules, depending on 
the properties of the analytes (Chughtai and Heeren 2010). Simultaneous detection of lipids 
and proteins is therefore difficult to accomplish with this method, especially since detection of 
proteins usually requires additional rinsing steps to remove lipids and other interfering 
molecules from the surface before application of the matrix. Furthermore, the spatial 
resolution of MALDI imaging is limited to the spot size of the laser beam, which normally is  
~50 µm, although, some studies have reported spatial resolutions in the 5-10 µm range, using 
a special instrumental setup (Römpp and Spengler 2013). Nevertheless, due to the soft 
ionization and dynamic molecular range, MALDI imaging has become a popular tool in the 
biomedical field for detection of peptides and proteins (Caprioli et al. 1997; Hanrieder et al. 
2011; Rohner et al. 2005), as well as lipids (Benabdellah et al. 2010; Cerruti et al. 2012) and 
pharmaceuticals (Stoeckli et al. 2007) in tissue sections. 
Another IMS technique that can be used for imaging of tissue samples is time-of-flight 
secondary ion mass spectrometry (ToF-SIMS); (Claudia Bich et al. 2015; Alain Brunelle and 
Laprévote 2009; Passarelli and Winograd 2011). In ToF-SIMS, a focused ion beam is pulsed 
upon the sample to produce secondary ions, which are emitted from the sample surface 
without the need for a matrix. The emitted secondary ions are collected and separated into a 
mass spectrum for identification of molecular species on the surface. Using this method, 
molecules can be detected and localized on the sample surface with a spatial resolution  
<1 µm. However, because of fragmentation of the molecules during sputtering, only ions up 
to ~2 kDa are typically created with this technique, limiting the detection to molecules with 
low mass, such as lipids, while larger molecules, such as proteins, become too fragmented to 
be detected as intact molecules. Nevertheless, due to the label-free detection of many other 
biomolecules with high spatial resolution, ToF-SIMS has been successfully used for imaging 
of biological samples, for example for investigation of the lipid distribution in mouse brains 
tissue (Nygren et al. 2005; Sjövall et al. 2004; Touboul et al. 2004), muscle tissue (Tahallah et 
al. 2008), adipose tissue (Belazi et al. 2009) and bone tissue (Henss et al. 2016). Lipid 
distributions have also been successfully mapped in individual cells, for example in 
tetrahymena thermophila during mating (Ostrowski et al. 2004), and in single neurons 
(Monroe et al. 2005). Other small compounds, such as pharmaceuticals, have also been 
investigated with ToF-SIMS, for example for determination of the distribution of specific 
drugs in skin tissue (Sjövall et al. 2014). 
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ToF-SIMS is usually conducted under so called static SIMS conditions, in which the data is 
obtained from a sample surface that has not yet been significantly damaged by the (pulsed) 
primary ion beam. An IMS technique similar to ToF-SIMS is dynamic SIMS, which uses a 
continuous primary ion beam and instead interrogates a sample surface that is under 
continuous alteration by the primary ion beam (Boxer et al. 2009). Advantages with dynamic 
SIMS are the high sensitivity and the high spatial resolution that can be obtained (<50 nm), 
for example, using the so called NanoSIMS instrument (Guerquin-Kern et al. 2005). 
However, the molecular structures on the sample surface are normally lost during the ion 
bombardment, resulting in the production of mostly monatomic or diatomic secondary ions. 
Therefore, isotopic labels are typically used to obtain molecular information from the sample 
surface, for example through incorporation of metabolic stable isotope-labeled lipids in 
cultured cells (Frisz et al. 2013; Yeager et al. 2016). To be able to detect proteins with 
NanoSIMS, functionalized antibodies tagged with different isotopic metal reporters have been 
used, enabling the detection of ten different targets at the same time in a tissue sample from 
human breast tumors (Angelo et al. 2014). Lipids, however, remained unseen with this 
approach. A similar approach for detection of a specific protein in cells has also been used, by 
targeting the protein with antibodies tagged with fluorinated gold colloids, while at the same 
time detecting lipids labeled by incorporated metabolic isotopes (Wilson et al. 2012). Others 
have previously also used isotope-labeled metabolites to detect specific biomolecules with 
NanoSIMS (Steinhauser and Lechene 2013). This method, called multi-isotope imaging mass 
spectrometry (MIMS), has revealed both protein distributions (using isotope-labeled amino 
acids) (Zhang et al. 2012), and DNA synthesis (using isotope-labeled thymidine) (Steinhauser 
et al. 2012) at subcellular resolution. 
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Combining IMS with microscopy 
Instead of using only one of the mentioned imaging techniques above, it is also possible to 
combine the imaging techniques for subsequent detection of different biomolecules. In a study 
by Solé-Domènech et al., the distributions of cholesterol and sulfatides were studied in brain 
tissue from an AD transgenic mouse model and correlated to Aβ deposits using confocal laser 
scanning fluorescence microscopy (Solé-Domènech et al. 2013). To avoid redistribution of 
lipids during the tissue preparation, the Aβ deposits were first stained in an adjacent tissue 
section, for localization of regions of interest. The untreated other half of the tissue section 
was then analyzed with ToF-SIMS in the identified regions of interest for localization of 
lipids, and then subsequently stained for various biomarkers and imaged with fluorescence 
microscopy to confirm that matching regions were indeed examined. In this way, Aβ deposits 
could be correlated with the cholesterol distribution in the tissue, together with activated 
microglia and astrocytic processes (Fig. 2). A similar study also investigated the distribution 
of cholesterol in cortical brain tissue from AD patients and tried to correlate the amount of 
cholesterol with subsequent staining of Aβ and Tau (Lazar et al. 2013). Although no clear 
correlation was found between the increased cholesterol distribution and the deposits, it was 
found that AD patients had significantly higher amounts of cholesterol in the cortex compared 
to control samples.  
Another study has investigated the feasibility of imaging the same tissue section with optical 
microscopy and ToF-SIMS, by investigating the lipid distribution before and after histological 
staining (C. Bich et al. 2013a). Here, it was found that when excluding the fixation and 
dehydration steps from the staining protocol, it was still possible to image the tissue section 
with ToF-SIMS for localization of cholesterol in major anatomical regions, although, some 
distention of the tissue was observed when comparing the stained tissue section with a 
reference sample. A similar study investigating the feasibility of MALDI imaging on stained 
tissue sections has shown that some stains can interfere with the ionization process, by 
suppressing certain molecules in the mass spectrum (Chaurand et al. 2004). However, by 
staining the tissue section after MALDI imaging, it was possible to correlate major 
histological features with several different protein markers detected in the MALDI mass 
spectrum (Deutskens et al. 2011). These studies further strengthen the need for 
complementary analyses with different techniques for detection of a broader range of 
molecules in the same tissue section. 
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Figure 2 (a-b) Colocalization of the cholesterol distribution (yellow) and Aβ deposits (p-FTAA, blue) in AD 
mouse brain tissue using ToF-SIMS imaging and confocal fluorescence microscopy, respectively. (c-d) 
Detection of activated astrocytic processes (GFAP, green) and reactive microglia (Iba1, red, indicated with 
arrows) in the vicinity of the same Aβ deposit as in (a), stained with p-FTAA (yellow). Surrounding cell nuclei 
are stained with BOBO-1 (blue). mc = maximum counts in one pixel. Reprinted with permission from (Solé-
Domènech et al. 2013). Copyright 2012, Springer-Verlag. 
2.3 LIPOSOMES FOR DETECTION OF BIOMOLECULES ON SURFACES 
A liposome is a water containing vesicle surrounded by a lipid membrane, called a lipid 
bilayer (Fig. 3A) (Alberts 2002). The formation of liposomes is highly dependent on the 
nature of the lipid molecules, and different lipids are prone to form different forms of 
assemblies. The most common type of lipids forming lipid bilayers is phospholipids. 
Phospholipids consist of a polar head group and two hydrophobic fatty acid tails, which, in 
general, give the molecule a cylindrical shape. The different parts of the phospholipid also 
give the molecule its amphiphilic properties, where the polar head group favors an aqueous 
environment and the tails prefer a hydrophobic environment. This is why phospholipids tend 
to spontaneously form lipid assemblies in an aqueous solution, since these structures are 
energetically favorable by providing the head group to be in contact with the surrounding 
water while the tails are closely packed within the assembly. It is because of the cylindrical 
shape of the phospholipids that these lipids are prone to form lipid bilayers and liposomes, 
since in this assembly the molecules become closely packed and thereby protected from the 
environment. However, depending on the size of the head group and the tails, some 
phospholipids can also form a more cone-like structure, which are more prone to accumulate 
in curved membranes (Ostrowski et al. 2004). 
Since phospholipids form lipid bilayer assemblies spontaneously in an aqueous solution, 
liposomes can easily be produced artificially, usually through drying of a dissolved lipid 
mixture on a surface, followed by hydration in a desired buffer and sonication and/or 
membrane extrusion, to produce homogeneous and unilamellar liposomes of a particular size 
(Jousma et al. 1987; Patil and Jadhav 2014). In this way, liposomes with different lipid 
compositions can be produced. The included lipids can also be labeled with different tags, 
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such as fluorophores or ligands, thereby functionalizing the liposomes in different ways 
(Gunnarsson et al. 2010a). By including fluorescently labeled lipids, the liposomes can be 
detected and studied with fluorescence microscopy. One ligand often used to functionalize 
biomolecules is the vitamin biotin, which is a small molecule that binds to the proteins avidin, 
streptavidin and the bioengineered variant neutravidin (Nilebäck et al. 2011). Since these 
proteins contain four binding sites for biotin, they can bind to different biotinylated molecules 
simultaneously, thereby linking the biomolecule with other molecules containing a biotin-tag, 
such as an antibody (Fig. 3B). In this way, specific proteins of interest can be labeled with 
biotinylated liposomes, for subsequent detection with fluorescence microscopy, or with ToF-
SIMS, using specific deuterated lipids to distinguish the liposomes from the native lipids in 
the tissue (Gunnarsson et al. 2010a). 
The antibody can then be changed depending on the target of interest, and by varying the lipid 
composition in the liposomes this approach can also be used for detection of multiple targets 
at the same time. However, in this case the antibodies need to be directly conjugated to each 
liposome, for unique identification. This can be achieved by including a lipid with a reactive 
group, such as a maleimide, in the liposomes, and introducing thiol groups on the antibodies, 
since thiols react spontaneously with maleimides to form a stable chemical bond (Jølck et al. 
2010; Nobs et al. 2004). These antibody-conjugated liposomes, so called immunoliposomes, 
have been used previously as drug delivery vehicles, for targeted delivery of drugs to specific 
sites of the body (Allen and Cullis 2013; Huwyler et al. 1996; Park et al. 1995). In this work, 
we show that the immunoliposomes, and other protein-conjugated liposomes, can be used for 
biosensing purposes, for multiplexed detection of molecules at biological surfaces (Fig. 3C). 
 
Figure 3 Schematic illustrations of (A) a liposome as a vesicle surrounded by a lipid bilayer, (B) the liposome-
based approach for detection of the protein of interest (red) by using biotinylated antibodies (dark blue) followed 
by the biotin-binding protein neutravidin (green) and biotinylated liposomes (light blue) with fluorescent tags 
(yellow), and (C) antibody-conjugated liposomes (immunoliposomes) for detection of multiple targets on the 
surface. 
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3. EXPERIMENTAL METHODS 
 
The main methods used in this thesis were quartz crystal microbalance with dissipation 
monitoring (QCM-D), fluorescence microscopy, time-of-flight secondary ion mass 
spectrometry (ToF-SIMS) and matrix-assisted laser desorption/ionization (MALDI). QCM-D 
was used to investigate and verify specific binding of the liposomes to targets on model 
surfaces. Fluorescence microscopy was used to verify specific binding of antibodies to Aβ in 
tissue sections, either using fluorescent secondary antibodies or with liposomes containing the 
fluorescent markers, as well as for detection of liposome binding to model surfaces. ToF-
SIMS was the central and most critical experimental method used, as it provided the parallel 
imaging of native lipids and liposomes bound to Aβ deposits in tissue sections, but also 
multiplexed target detection on model surfaces. Furthermore, MALDI imaging was used as a 
complementary method to gain deeper knowledge about the Aβ deposit composition and other 
proteins in the microenvironment.  
3.1 LIPOSOME PREPARATION AND CONJUGATION WITH ANTIBODIES 
The liposomes were prepared according to the film method (Jousma et al. 1987), by mixing 
the desired composition of lipids, dissolved in methanol/chloroform, in a round bottom flask 
followed by drying, first in a flow of nitrogen gas and then at reduced pressure using a 
vacuum pump for 1 hour. The dried lipid film was then hydrated in the desired buffer, which 
was phosphate buffered saline (PBS, pH 7.4) for the biotinylated liposomes and sodium 
acetate (NaAc, pH 5) for the immunoliposomes. The hydrated lipids were extensively mixed 
and vortexed for 5 min and then extruded 11 times through a polycarbonate membrane filter 
with a specific pore size, usually 100 or 200 nm, to form small unilamellar vesicles. The size 
distribution of the formed liposomes was measured using nanoparticle tracking analysis 
(NTA, NanoSight LM10, Malvern Instruments Ltm). 
To prepare the immunoliposomes, liposomes containing 10% of a lipid with a maleimide 
group and a polyethylene glycol (PEG) spacer (DSPE-PEG(2000) Maleimide) were used. The 
chosen antibody was then prepared with a thiolating agent, called Traut’s reagent (2-
Iminothiolane), to convert primary amines on the antibodies into thiol groups. The thiolated 
antibodies were then added to the liposomes for conjugation using the reactivity of maleimide 
to thiol (Jølck et al. 2010; Nobs et al. 2004). After 1 hour of incubation, the antibody-
liposome conjugation was discontinued by a filtration step, to separate the non-conjugated 
antibodies from the immunoliposomes. For this purpose, a gel column packed with 
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Sepharose-4B was used, to be able to separate the molecules according to size (so called size 
exclusion). The antibody-liposome mixture was added to the top of the column and eluted by 
rinsing with PBS. The eluted sample was collected into different fractions, containing 250 µl 
each, which were analyzed further with a spectrofluorometer to detect the liposomes (labeled 
with Rhodamine) and the antibodies (labeled with Alexa Fluor 430) in the different fractions. 
Since the liposomes are much larger than the antibodies, they were eluted in the first fractions, 
while the antibodies were retained by the porous network in the column and thereby 
efficiently separated from the liposomes. The fractions that were found to contain the 
immunoliposomes were pooled together and diluted to 0.5 mg/mL in PBS and stored at 4°C 
until use. An overview of the immunoliposome preparation protocol can be seen in Fig. 4. 
 
Figure 4 Schematic illustration of the preparation of immunoliposomes. (1) First the liposomes are made by 
extrusion of a hydrated lipid mixture, including a lipid with a PEGylated maleimide head group (green) and a 
fluorescently labeled lipid (yellow), through a polycarbonate membrane with defined pore size. (2) The 
antibodies are modified with Traut’s reagent, to convert primary amines to thiol groups. (3) The antibodies are 
added to the liposomes to produce a stable conjugation of the thiols to the maleimide groups in the liposomes. 
The preparation protocol is finalized with a gel filtration step (4) to separate non-conjugated antibodies from the 
immunoliposomes by size exclusion. 
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3.2 QCM-D 
QCM-D is a technique that can be used to measure the mass and viscoelastic properties of 
molecules adsorbing onto the surface of the quartz crystal sensor, by utilizing the 
piezoelectric properties of quartz (Höök et al. 1998; Rodahl et al. 1995). By applying an AC 
voltage, the crystal can be excited to oscillate at its resonance frequency. When molecules are 
adsorbed on the crystal surface, a shift in the resonance frequency (∆f) can be measured that 
depends on the change in mass on the sensor surface. Another parameter that is measured 
with QCM-D is the energy dissipation (∆D), which represents the loss of energy from the 
sensor surface to the surrounding fluid and depends on the viscoelastic properties of the 
molecules on the surface. If the adsorbed molecular layer is very rigid, the energy dissipation 
is low (∆D ~ 0). In this case, the frequency shift is directly proportional to the molecular mass 
and the coupled solvent, according to the Sauerbrey relation (Sauerbrey 1959): 
∆	 =  ∆ 
where C is the mass-sensitivity constant (C = 17.7 ng/(cm3 Hz) for quartz crystals with a 
fundamental resonance frequency of 5 MHz) and n is the overtone number (1, 3, 5...). Here, it 
is also assumed that (i) the added mass is small compared to the crystal mass, (ii) is 
distributed in a uniform layer on the surface and (iii) that the layer is attached under no-slip 
conditions during the oscillation. However, if the absorbed layer is less rigid, the molecules 
will form a soft film on the crystal surface that is deformed during the oscillation. The 
formation of these surfaces is characterized by high dissipation shifts (∆D > 0) and in this 
case the mass will not be directly proportional to the frequency shift. To estimate the adsorbed 
mass, the viscoelastic property needs to be accounted for, and therefore the Sauerbrey 
equation cannot be used. Instead a viscoelastic model can be applied; such as a Voight-based 
model (Voinova et al. 1999), by which the thickness, δ, or the density, ρ, of the adsorbed layer 
can be estimated. However, to solve the unknown parameters in this equation it is important 
to measure at different overtones simultaneously (Höök et al. 2001; Reimhult et al. 2002). 
In comparison with other biosensing techniques, such as surface plasmon resonance, QCM-D 
does not only measure the mass of the adsorbed molecules on the sensor surface, but also the 
hydration and trapped water in the adsorbed layer (Bingen et al. 2008; Höök et al. 2001). This 
can be water trapped inside for example lipid vesicles, in between or underneath the 
molecules, or in any other way bound to the adsorbed molecular layer, such as hydrated 
  
 
18 
polymers chains. High amounts of trapped water typically increase the energy dissipation of 
the surface, but also rigid films (with low ∆D) can entrap significant amounts of water. 
Besides using QCM-D to determine the mass or thickness of the adsorbed film of molecules, 
it can also be used to investigate different kinds of interactions on the sensor surface 
(Nilebäck et al. 2011; Speight and Cooper 2012), such as protein–protein interactions (Höök 
et al. 1998), DNA hybridization (Gunnarsson et al. 2008), virus attachment to lipid 
membranes and even for live cell studies (Frost et al. 2013; Tymchenko et al. 2013). It can 
also be used to monitor the adsorption of liposomes onto a surface and the subsequent 
formation of a supported lipid bilayer (Keller and Kasemo 1998). By investigating the 
frequency and dissipation shifts caused by sequential binding of different molecules to the 
surface, one can also distinguish different molecules from each other, depending on their 
viscoelastic properties on the surface. An example of the frequency and dissipation shifts 
obtained upon binding of different kinds of molecules to a model surface is shown in Fig. 5. 
Here, one can clearly see the difference in response, in particular in dissipation shift, when the 
large water-containing immunoliposomes (circles) bind to the surface in comparison to the 
binding of the much smaller and more rigid antibodies (squares). 
 
Figure 5 (A) A schematic illustration of an immunoliposome and antibodies binding to a model surface 
containing the biotinylated polymer PLLgPEG. (B) QCM-D graph showing the frequency (blue) and dissipation 
(red) shifts measured when different molecules are adsorbed on the quartz crystal surface; (1) PLLgPEG-biotin 
and (2) immunoliposomes (circles) versus antibodies (squares). 
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3.3 FLUORESCENCE MICROSCOPY 
Fluorescence microscopy is a widespread method used for imaging of molecules in biological 
samples, such as living cells and tissue samples (Swedlow 2012). The basic principle behind 
the method is to use fluorophores as labels for the target of interest (Lichtman and Conchello 
2005). Fluorophores are molecules with the ability to absorb and emit light at specific 
wavelengths. One example of a naturally occurring fluorescent molecule is the green 
fluorescent protein (GFP), which has been found in the jellyfish Aequorea victoria 
(Shimomura et al. 1962). Similar proteins have also been found in corals, and are extensively 
used today in biological studies for localization of specific proteins within the cell, by co-
expressing the protein of interest with the GFP sequence, thereby creating an artificial tag 
within the cell (Chalfie et al. 1994).  
There are many other biomolecules that possess fluorescent properties, and these molecules 
are referred to as intrinsic fluorophores. One example is aromatic amino acids, such as 
tryptophan, tyrosine and phenylalanine, which can absorb light in the UV range (260-295 nm) 
(Lakowicz 2006). Other common intrinsic fluorophores are enzyme cofactors, such as NADH 
and flavins. Also, common components of intact tissue have fluorescent properties, which are 
typically more dependent on the structure of the tissue than on specific fluorophores. These 
intrinsic fluorophores and structures often give rise to autofluorescence in the tissue. DNA 
and lipids, on the other hand, are often nonfluorescent. Some extrinsic fluorophores bind 
spontaneously to specific biomolecules and can therefore be used as probes. One example is 
4',6-diamidino-2-phenylindole (DAPI), which binds selectively to DNA and can thus be used 
to stain the DNA-rich nuclei insides cells. In other cases, IHC can be used for labeling of 
specific molecules, as described in section 2.2. 
Since different fluorophores emit light at different wavelengths, it is possible to use several 
fluorophores at the same time, allowing for simultaneous imaging of various molecules. 
However, it is only possible to use fluorophores that do not overlap each other in the 
excitation or emission spectra; otherwise the fluorescence signals cannot be distinguished 
from each other. This phenomenon of fluorescence interference between different 
fluorophores is called “cross-talk”, and limits the use to 3-4 fluorophores at the same time for 
specific identification of each molecule, as visualized in figure 6. In this figure, one can also 
see that fluorophores with a broader excitation or emission spectrum, such as DAPI (blue), 
decreases the number of additional fluorophores that can be used at the same time. Therefore, 
new fluorophores are continuously developed to achieve as specific fluorescent markers as 
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possible and to increase the multiplexing capability. One such type is the recently developed 
Alexa Fluor dyes (Molecular probes, Invitrogen), which includes fluorophores that span all 
the way from near-UV to near-IR light. Besides the wide range of wavelengths, these new 
fluorophores are also less prone to photobleaching, which otherwise is a common 
disadvantage of fluorescent probes (Berlier et al. 2003). 
 
Figure 6 Normalized excitation (dotted lines) and emission (straight lines, filled curves) spectra of four different 
fluorophores, illustrating the potential risk of spectral overlap when using too many fluorophores at the same 
time. Blue = DAPI, green = Alexa Fluor 488, yellow = Rhodamine red, red = Alexa Fluor 647. The graph was 
created using the online tool Fluorescence SpectraViewer (ThermoFisherScientific 2016). 
One of the greatest advantages of fluorescence microscopy, as compared to bright-field 
microscopy where the sample contrast is produced by absorbance of light in the sample, is the 
high contrast between the fluorescence signal and the background of the surrounding 
specimen. To be able to detect only the emitted fluorescence from the sample, conventional 
wide-field fluorescence microscopes are equipped with specific filter cubes that are specially 
designed for each fluorophore (Lichtman and Conchello 2005). The filter cube consists of 
three parts; an excitation filter, a dichroic mirror and a barrier (emission) filter. The excitation 
filter selects a specific wavelength from the light source that can pass to the specimen. The 
selected wavelength is directed to the sample using a dichroic mirror, which reflects the light 
onto the sample and, at the same time, allows selected emitted light of longer wavelength to 
pass through to the detector. In this way, the excitation light will not reach the detector. The 
emitted light from the sample that passes through the dichroic mirror is then further filtered by 
the barrier filter, which allows only specific wavelengths to pass through to the detector. 
Using different sets of filter cubes, the sample can be analyzed further for subsequent 
detection of different fluorophores in the sample. One way to increase the multiplexing 
capability, and to reduce cross-talk between the different fluorophores, is to choose narrow-
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band filter cubes, which will allow only very narrow range of wavelengths to reach the 
detector. Of course, this will also result in lower signal from the fluorophores compared to 
using broad-band emission filters. 
A disadvantage with the conventional wide-field fluorescence microscopy is the lack of 
ability to focus in depth of the tissue samples, resulting in blurred subcellular structures at 
high magnifications. The reason for this effect is that the collected light does not only 
originate from the focused field of view, but from the entire depth of the tissue. A solution to 
this problem is to use confocal microscopy (Smith 2008). In confocal microscopy, a small 
probe of light is focused by a laser beam and scanned through the sample at a very specific 
sample depth, called the optical section. Thus, only fluorophores in this specific volume are 
excited. The emitted light is then further filtered by passing through a small aperture, so-
called pinhole, before reaching the detector, to exclude out-of-focus light. The resulting 
images thus display much higher contrast than what can be obtained with a wide-field 
microscope, however, at the cost of fluorescent signal intensity. Nevertheless, by scanning the 
sample multiple times at varying depth, 3D images of the sample can be constructed. 
Confocal microscopy can thus be of great advantage when imaging small structures in 
biological samples. 
3.4 TOF-SIMS 
ToF-SIMS is an analytical technique that can be used to analyze the chemical composition of 
analytes on a solid surface. By using a beam of ions, called primary ions, to bombard the 
sample, secondary ions specific to the sample surface are created (Benninghoven 1973). The 
emitted secondary ions are extracted by an electrostatic field into a time-of-flight analyzer 
where they are separated according to their mass versus charge-ratio (m/z) and detected to 
produce a mass spectrum (Chait and Standing 1981).  
The primary ions are generated in an ion source, such as a liquid metal ion gun (LMIG), 
which extracts and focuses the ions into an ion beam (A. Brunelle et al. 2005). The primary 
ion beam is rastered over the sample surface to create secondary ions from different positions 
on the sample surface, thus collecting information about the molecular composition in each 
position. In the time-of-flight analyzer, the collected secondary ions are accelerated to the 
same kinetic energy and allowed to propagate in a field-free region, where they are separated 
according to m/z ratio, since ions with higher mass travel the distance with lower velocity than 
ions with lower mass.  
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The measured time of flight can be used to calculate the mass of extracted ions by using the 
formulas; 
 = 	 
     
	 =     =    =   
where m and v are the mass and velocity, respectively, and z  is the charge (in most cases ± 1) 
of the secondary ion, whereas L is the length and U is the electrostatic potential (relative to 
the sample) of the time-of-flight analyzer (Vickerman and Briggs 2001). Thus, by measuring 
the time needed to reach the detector, the distribution of secondary ions can be visualized in a 
mass spectrum according to the m/z ratio. By selecting a peak in the mass spectrum that 
corresponds to a specific molecule, 2D images can be generated that show the signal intensity 
(that is, counts of secondary ions) of the selected ion in each position of the sample. A 
simplified illustration of the process is shown in figure 7.  
 
Figure 7 An illustration of the basic principle of ToF-SIMS imaging. An ion source generates a primary ion 
beam, which is focused onto the sample. As the sample is bombarded by the primary ions, secondary ions are 
formed and emitted from the surface. The emitted secondary ions are then collected and accelerated into a time-
of-flight analyzer where they are separated according to mass versus charge (m/z) ratio and visualized in a mass 
spectrum. From this spectrum images can be generated, showing the spatial distribution of different molecules 
on the sample surface. In this example, an overlay image visualizing the distribution of PO2- (red), CNO- (green) 
and cholesterol (blue) ions in a mouse brain section is shown. 
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The collision of primary ions on the sample surface results in extensive fragmentation of the 
molecules in the topmost layer (~10 nm) of the surface (Mas et al. 2008). A small percentage 
(< 1%) of the fragmented molecules is emitted from the surface as ions. Since the collision 
results in both negative and positive ions (as well as neutral molecular fragments), the sample 
is often analyzed twice, once for each polarity of the ions to be collected. Since the primary 
ions cause molecular damage on the surface of the sample, it is important that the surface area 
impacted by a specific primary ion, also referred to as the damage cross-section (σ), is only 
analyzed once to ensure a native sample surface.  Therefore, analysis is often performed in the 
so called static mode, which means that very low doses of primary ions are used. The limit of 
primary ion dose density (PIDD) that can be used in this mode is called the static SIMS limit, 
and is proportional to the inverse of the damage cross-section (1/ σ), which depends on the 
type of primary ion used (A. Brunelle et al. 2005). However, it is generally stated that the 
PIDD should be lower than 1013 ions/cm2 to ensure a native sample surface (Vickerman and 
Briggs 2001), even though surface damage effects, such as decrease in secondary ion yields, 
have been observed already at a PIDD of 1012 ions/cm2 (Thiel and Sjovall 2015). 
To avoid charging effects in insulating samples, including most biological samples, a pulsed 
low-energy electron flood gun is often used for charge compensation. The flood gun applies a 
current of electrons over the sample, in-between the pulses with primary ions, to neutralize 
the surface. The electron dose density is kept low to prevent damage to the surface. However, 
when analyzing a surface for a long time, electron induced surface modifications might occur 
and need to be accounted for (Gilmore and Seah 2002). 
Cluster primary ion beams 
A disadvantage with analysis in the static mode is a low yield of secondary ions. To improve 
the yield, cluster ions, such as Au3+ or Bi3+, are often used instead of the historically used 
monatomic ions, such as Ga+ or In+, as primary ion beams  (A. Brunelle et al. 2005). Cluster 
ions have lower energy per constituent which results in less penetration of the sample and a 
more spread-out energy distribution in the topmost surface region of the sample. Cluster ions 
can therefore increase the yield of secondary ions from the surface, especially of molecular 
ions. Another advantage of using cluster ion beams is that the low penetration depth causes 
less molecular damage to the sample, enabling analysis beyond the static SIMS limit and even 
depth profiling of the sample, by using for example C60+ (Fletcher et al. 2007; Jones et al. 
2007, 2008) or Argon (Arn+, where n > 500) cluster ion beams, also referred to as gas cluster 
ion beams (GCIB) (Angerer et al. 2015a; Claudia Bich et al. 2013b; Shard et al. 2012; 
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Yamada et al. 2010). Another recently developed promising GCIB is the water-containing 
((H2O)6000+) cluster ion beam (Berrueta Razo et al. 2014). These larger cluster ion beams have 
shown to produce higher yield of molecular ions, especially of intact lipid molecules (~500-
900 m/z) (Razo et al. 2015). However, these large cluster ion beams are also more difficult to 
focus, resulting in lower spatial resolution (~1 µm for C60+ and ~10 µm for the GCIB) (Razo 
et al. 2015). Therefore, these ion beams are often used in a dual-ion beam setting, where the 
large cluster ions are used to sputter off material from the surface, followed by imaging with a 
second ion beam, such as Bi3+ (Claudia Bich et al. 2013b; Breitenstein et al. 2007). 
Mass resolution versus spatial resolution 
ToF-SIMS can be used in different modes; either optimized for high mass resolution or for 
high spatial resolution (A. Brunelle et al. 2005; Mas et al. 2008). To obtain high mass 
resolution, a buncher is used to produce very short ion beam pulses. This mode produces 
spectra with narrow peaks, at a mass resolution of m/∆m up to ~10 000, allowing for effective 
separation of ions with similar mass. However, this mode also results in lower spatial 
resolution (~3-4 µm), since the short ion pulses are difficult to focus into smaller spots. To 
obtain high spatial resolution, longer pulses are used to produce more focused ion beams, 
resulting in a spatial resolution down to ~100 nm (Gunnarsson et al. 2010b). However, since 
the duration of pulses is longer, the peaks in the mass spectrum becomes wider, which might 
result in lower specificity of the detected ions.  
In addition to the focus of the primary ion beam at the sample surface, the spatial resolution 
that can be obtained in the ion images is  dependent on the so called useful lateral resolution 
(∆L), which provides the surface area needed to detect a sufficient number (N) of secondary 
ions of the molecule of interest to be considered a significant signal (A. Brunelle et al. 2005). 
The useful lateral resolution is given by: 
∆ =  =

(  ) 
where E is the detection efficiency (number of secondary ions per cm2), Y is the secondary ion 
yield (number of secondary ions per primary ion) and σ is the disappearance (damage) cross-
section, which is the mean area damaged by one primary ion. The useful lateral resolution is 
thus highly dependent on the investigated molecule, as well as the type of primary ion beam 
used in the analysis. For example, ∆L for cholesterol ions (m/z = 385) in a rat brain section 
was found to be ~500 nm using a Bi3+ primary ion beam at 25 keV (A. Brunelle et al. 2005), 
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whereas the phosphocholine ion (m/z = 184) in a supported lipid bilayer was found to have a 
∆L of ~100 nm with similar settings (Gunnarsson et al. 2010b). 
Matrix effects 
There are many factors that influence the formation of secondary ions from the surface. The 
basic SIMS equation is: 
 =  ±"# 
where Im is the secondary ion current of the species m, Ip is the primary ion current, Y is the 
sputter yield of secondary ions per primary ion impact, α± is the ionization probability of a 
particular ion, θ is the fractional surface concentration of m and η is the transmission of the 
instrument (Vickerman and Briggs 2001). Thus, the emission of secondary ions is highly 
dependent on the properties of the species, and the surrounding chemical environment. The 
latter is referred to as the matrix effect. One example of problems that can occur with matrix 
effects is the occurrence of salt on the surface, which can suppress the emission of some 
molecular ions while other ions are enhanced (Jones et al. 2007; Robinson and Castner 2013). 
Other factors that might influence the emission of secondary ions is the occurrence of specific 
lipids on the surface, such as cholesterol or phosphatidylcholine, which can suppress or 
enhance the emission of other molecules in the surroundings (Angerer et al. 2015b; Jones et 
al. 2008; Razo et al. 2015). It is therefore important to investigate these factors in a controlled 
manner, to be able to make an estimate of the amount of a particular substance on the surface. 
Sample preparation 
One thing that is important to consider when imaging biological samples is the sample 
preparation. Since ToF-SIMS analysis is performed in an ultrahigh vacuum chamber, the 
sample has to be dried or frozen prior to analysis. If the sample contains a lot of salt, it can be 
valuable to rinse the sample in water or a volatile salt buffer, such as ammonium formate 
(AF), before analysis, to prevent the suppression of ions and the formation of salt adducts 
(Jones et al. 2007; Malm et al. 2009; Robinson and Castner 2013). To preserve wet samples, 
cryofixation is often used, which involves plunge-freezing (PF) and freeze-drying (FD). PF 
refers to freezing the sample very fast in for example liquid propane at −185°C. In this way, 
the water molecules in the sample will not form normal ice crystals, but instead amorphous, 
non-crystalline ice in a process called vitrification (Severs 2006). In this way, structural 
damage of the sample can be prevented. The sample then has to be freeze-dried slowly in a 
vacuum chamber at low temperatures (< −80°C) to allow the water molecules to sublimate 
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from the surface, before recrystallization starts to occur. However, if the sample does not 
contain much water, such as thin tissue sections, it might be enough to just freeze-dry the 
sample at room temperature prior to analysis. 
 
 
Figure 8 Illustration of the different steps that can be involved in the preparation of tissue samples prior to ToF-
SIMS analysis; (A) rinsing with a volatile buffer, such as ammonium formate (note that the colors are just 
indicative of the liquid content and not representative of the color of the buffer), (B) plunge-freezing in liquid 
propane at −185°C, and (C) freeze-drying in vacuum chamber on a cold support. 
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3.5 MALDI 
MALDI mass spectrometry is an IMS method that allows for detection and localization of 
different kinds of molecules in complex biological tissue samples (Caprioli et al. 1997; 
Chughtai and Heeren 2010; Pol et al. 2010; Rohner et al. 2005). The principle is similar to 
ToF-SIMS imaging, but instead of using a primary ion beam, the sample is irradiated with a 
laser beam. Furthermore, MALDI is based on embedding analytes of interest in a crystalline 
UV absorbing matrix that can absorb and transfer energy upon laser irradiation, leading to ion 
formation of the analytes. This results in very soft ionization of the molecules, with the 
formation of intact molecular ions in the range up to 100 kDa, and with nanomolar sensitivity 
(Benabdellah et al. 2010; Cornett et al. 2007). The desorbed and ionized molecules are then 
usually extracted and separated in a time-of-flight analyzer (as described in section 3.4), 
resulting in a mass spectrum with various peaks corresponding to the molecular mass of the 
molecules on the surface. By rastering the laser beam over the sample surface, 2D images can 
be created, showing the signal intensity of the detected molecules in each position of the 
sample.  
Sample preparation 
Sample preparation is of vital importance in MALDI. Depending on the type of molecule of 
interest, different preparations and matrices can be applied for optimal extraction of analytes. 
The matrix solution consists of the crystalline organic acid dissolved in an organic solvent and 
an additional acid, such as trifluoroacetic acid (TFA) or formic acid (Chughtai and Heeren 
2010). The organic solvent, which often consists of ethanol, methanol or acetonitrile, is used 
to mix the matrix with extracted analytes from the sample and then evaporate from the 
surface, resulting in the formation of matrix crystals, including molecules from the sample, on 
the surface. By mixing the organic solvent in water, the evaporation rate can be tuned, 
allowing for slower crystal formation which affects the amount of analytes extracted from the 
surface. The concentration of the organic acid is another factor affecting the crystal formation 
and coverage on the surface. Higher concentrations results in greater crystal coverage on the 
surface but also faster crystal formation, which reduces the amount of extracted analytes. On 
the other hand, too low concentration of the organic acid results in too slow crystal formation, 
which may result in diffusion of analytes on the surfaces, thus affecting the spatial resolution. 
The purpose of the additional acid is to provide more protons to the desorbed molecules, 
thereby enhancing the ionization of the analytes. 
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The size and distribution of the matrix crystals is also dependent on the type of matrix used. 
One commonly used matrix is sinapinic acid (3,5-dimethoxy-4-hydroxycinnamic acid, SA), 
which has been shown to form evenly distributed crystals on the surface (Schwartz et al. 
2003). Other commonly used matrices are 2,5-dihydroxybenxoic acid (DHB), which tend to 
form larger crystals, and α-cyano-4-hydroxycinnamic acid (CHCA), which forms more dense 
crystals (Cerruti et al. 2012; Schwartz et al. 2003). The choice of matrix mainly depends on 
the molecules of interest; SA is commonly used for molecules with higher molecular weight, 
such as proteins, whereas DHB and CHCA are used for extraction of analytes with lower 
molecular weight, such as lipids and peptides, respectively (Chughtai and Heeren 2010).  
Another important preparation step when analyzing peptides and proteins is to wash the tissue 
section prior to matrix deposition, for removal of intrinsic salts and lipids that can interfere 
with the ionization process. This can be performed by immersing the tissue section briefly 
into different grades of ethanol, or other organic solvents, such as acetone and chloroform, or 
a volatile buffer such as ammonium formate (Martin-Lorenzo et al. 2014; Schwartz et al. 
2003). This preparation step is thus not necessary when analyzing lipids in the tissue.  
Furthermore, when using MALDI for imaging of biological samples, it is very important to 
apply the matrix in a proper way. Ideally, the matrix should result in small and clearly 
separated crystals, to prevent diffusion of analytes between the crystals and to achieve high 
spatial resolution. There are in principal two different techniques that can be used for this 
purpose; the first one is called spotting and the second spraying (Chughtai and Heeren 2010). 
In spotting, the matrix is applied as small droplet, either manually using for example a 
micropipette, or using automatic robotics, which can deposit picoliter sized droplets. 
However, even with the smallest droplets it is difficult to obtain smaller crystals than 100-200 
µm with this method. Using a spraying device, the matrix is applied as mist upon the sample, 
resulting in a homogenous thin film of solid matrix crystal on the surface. In this way, crystals 
as small as 20 µm are formed, thus improving the capability for imaging with high spatial 
resolution. It is important to make sure that the sample is not wetted too much during the 
application, since this will increase the lateral diffusion of analytes on the surface. Therefore 
the matrix is often applied in cycles with repeating wetting and drying steps. A schematic 
illustration of the basic principles of MALDI imaging is shown in figure 9.  
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Figure 9 Schematic illustration of the basic principles of MALDI imaging, showing (A) the preparation of tissue 
sections by matrix application and (B) production of surface specific ions using a laser beam for imaging of 
specific molecules by choosing a specific peak (m/z) in mass spectrum. 
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4. SUMMARY OF RESULTS 
 
In this section, a brief summary of the articles included in this thesis is presented and 
discussed. For more details, the reader is referred to the papers in the appendix. 
PAPER I - LIPOSOME BINDING FOR MULTIPLEXED BIOMOLECULE DETECTION AND IMAGING 
USING TOF-SIMS 
In paper I, the liposome approach for detection of biomolecules on surfaces was explored for 
the first time by detection of a single target, namely the protein neutravidin, at different 
concentrations on a model surface using biotinylated liposomes (Fig. 10A). For this purpose, 
the polymer PLLgPEG was used as a model surface, by mixing PLLgPEG at different ratios 
with biotinylated PLLgPEG, thereby creating model surfaces with different concentrations of 
biotin. Since neutravidin is a biotin-binding protein with four different binding sites, it can 
bind to the model surface and, at the same time, bind to other biotinylated molecules. In this 
way, biotinylated liposomes could be bound to the surface for subsequent detection with, for 
example, fluorescence microscopy and ToF-SIMS.  
This model system was first evaluated using QCM-D, by which the frequency and dissipation 
shifts were measured upon sequential addition of each component to the surface, as shown in 
figure 10B. In this figure, one can clearly see how PLLgPEG-biotin/PLLgPEG is adsorbed to 
all surfaces, followed by adsorption of neutravidin at varying degrees, depending on the 
concentration of biotin (0.08-10%) on the surface. At the lowest biotin concentration, the 
adsorption is barely noticeable with QCM-D, neither by measuring the frequency or the 
dissipation shift. However, subsequent addition of the biotinylated liposomes results in a 
concentration dependent binding of the liposomes to all the model surfaces. The large shift in 
dissipation when the liposomes are added to the surface ((iii) in Fig. 10B) demonstrate the 
viscoelastic properties of the liposomes, which in this case serve as signal amplification at the 
lowest concentration on the surface (0.08%), where the frequency shift is barely noticeable. 
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Figure 10 (A) Schematic illustration of the binding of biotinylated liposomes (iii) to a model surface containing 
PLLgPEG-biotin/PLLgPEG (i) and neutravidin (ii). (B) QCM-D graph showing the frequency (blue) and 
dissipation (red) shifts when binding each of the components to the model surface; (i) PLLgPEG-
biotin/PLLgPEG, (ii) neutravidin and (iii) biotinylated liposomes, at different fractions of PLLgPEG-biotin 
(0.08%, 0.4%, 2% and 10%) on the surface. (B) is Reprinted with permission from (Sjövall et al. 2014). 
Copyright, 2014 John Wiley and Sons. 
The same model system was used for detection of the liposomes at different concentration 
using fluorescence microscopy and ToF-SIMS imaging. For detection of the liposomes with 
fluorescence microscopy, fluorescently labeled lipids (DHPE-Rhodamine) were included in 
the liposomes. For specific detection with ToF-SIMS, deuterated phospholipids (D13-POPC) 
were used, which were easily detected by the different fragments of the phosphocholine head 
group in the mass spectrum (D13-PC+, m/z = 66, 98, 117, 179, 197 and 237). Six model 
surfaces with different biotin concentrations, ranging from 0 to 10% PLLgPEG-biotin were 
investigated with fluorescence microscopy. The results show a clear concentration-dependent 
binding of the liposomes up to 0.5%, where saturation seems to occur. Furthermore, low non-
specific binding (at 0% biotin) was detected. Similarly, ToF-SIMS analysis of model surfaces 
with 0 to 1% PLLgPEG-biotin showed a clear concentration dependency up to 0.5%. Also in 
this case, low non-specific binding was detected on the control surface (with 0% biotin), 
although it was found to be a bit higher than with fluorescence microscopy, indicating room 
for improvement of the preparation protocol. A graph summarizing the measured signal 
intensities of the liposomes detected with fluorescence microscopy and ToF-SIMS is 
presented in figure 11, showing similar biotin concentration dependencies for the two 
different imaging methods. 
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Figure 11 Graph showing the signal intensity (fluorescence intensities and ion counts, respectively) 
corresponding to liposome binding to model surfaces with different concentrations of PLLgPEG-biotin (0-10%), 
detected with fluorescence microscopy (blue) and ToF-SIMS (red). A clear concentration-dependency can be 
seen up to 0.5% PLLgPEG-biotin, where saturation seems to occur. Reprinted with permission from (Sjövall et 
al. 2014). Copyright 2014, John Wiley and Sons. 
As the can be seen in figure 11, the liposome binding seems to saturate around, or maybe 
slightly below, 0.5% PLLgPEG-biotin, both with fluorescence and ToF-SIMS imaging. 
However, this saturation was not observed in the QCM-D measurement (Fig. 10), where the 
frequency and dissipation shifts continued to increase up to 10% surface-coverage of 
PLLgPEG-biotin. When calculating at which surface coverage there should be enough 
binding sites to form a full monolayer of liposomes, taking into account that each liposomes 
has a diameter of ~200 nm and that the surface area of each PLLgPEG-biotin molecule is 
~100 nm2, a saturation would be expected at ~0.3% PLLgPEG-biotin molecules on the 
surface (see paper I for more details). This thus correlates well with the observed saturation 
detected with fluorescence microscopy and ToF-SIMS, but not with QCM-D. This indicates 
that the adsorption detected by QCM-D at higher concentration corresponds to a thicker, or 
denser, liposome-layer than a single monolayer, which would not be detectable with 
fluorescence microscopy or ToF-SIMS after saturation. Since each neutravidin on the surface 
has four binding sites for biotin, there are, at most, three additional binding sites free for 
binding after binding to the model surface. This might result in binding of several liposomes 
to each neutravidin, even though this is not very likely considering the large size of the 
liposomes compared to neutravidin. Nevertheless, the fact that several liposomes can bind to 
each neutravidin on the surface, and also the opposite: that each biotinylated liposome 
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(containing over 1000 of biotin-tags) can bind to several neutravidin molecules, makes this 
liposome approach a bit tricky when trying to detect and quantify single molecules on the 
surface.  
This liposome approach, using the biotin-avidin coupling, is also limited to a single target on 
the surface, and can thus not be used for multiplexed detection of different targets on the 
surface. Therefore, the liposome concept was developed further to include antibodies specific 
to the target of interest, instead of using the biotin-avidin coupling. These antibody-
conjugated liposomes, also called immunoliposomes, were further explored in paper III, for 
detection of Amyloid-β, and in paper V, for multiplexed detection of both biotin and the 
glycosphingolipid GM1. 
PAPER II - SIMULTANEOUS IMAGING OF AMYLOID-ΒETA AND LIPIDS IN BRAIN TISSUE USING 
ANTIBODY-COUPLED LIPOSOMES AND TIME-OF-FLIGHT SECONDARY ION MASS 
SPECTROMETRY 
In the second paper, the liposome approach for detection of a single target using the biotin-
avidin coupling was developed further to apply to a specific target, namely the peptide Aβ, in 
tissue sections from AD mouse brains. For this purpose, biotinylated antibodies specifically 
directed to Aβ was used, for subsequent binding of neutravidin and biotinylated liposomes 
(Fig. 12A). As described in paper I, the liposomes contained both fluorescently labeled lipids 
(DHPE-Rhodamine), and deuterated lipids (D13-POPC), for specific detection with 
fluorescence microscopy and ToF-SIMS, respectively. In this way, the same Aβ deposits 
could be detected in a region of the mouse brain (outlined by the square in Fig. 12B) with the 
antibody-coupled liposomes using both ToF-SIMS (Fig. 12C) and fluorescence microscopy 
(Fig.12E), showing very similar Aβ structures. Furthermore, investigation of the tissue section 
with optical (bright-field) microscopy, revealed very dense (dark) structures, indicating the 
presence of Aβ deposits (Fig. 12F). An adjacent control tissue section, subjected to the same 
preparation protocol but without the antibodies, was also investigated and did not reveal any 
significant nonspecific binding of the liposomes to the tissue in the same region of the mouse 
brain (Fig. 12D, the presence of Aβ is indicated by the circles). It could thus be concluded that 
the antibody-coupled liposomes bind specifically to Aβ deposits in the tissue sections. 
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Figure 12 Imaging of Aβ in an AD mouse brain tissue section using antibody-coupled liposomes. (A) Schematic 
illustration of the detection principle using biotinylated antibodies specific to Aβ, followed by binding of 
neutravidin and biotinylated liposomes for subsequent detection with fluorescence microscopy and ToF-SIMS. 
(B) ToF-SIMS image of detected liposomes (red) and cholesterol ions (green) in a region of the mouse brain 
containing the hippocampus and cortex. CC = corpus callosum, DG = dentate gyrus, CA1, CA2 and CA3 = 
subregions in hippocampus. (C, E) Image of detected liposomes in the hippocampal area (visualized by the 
square in B) detected with ToF-SIMS (C) and fluorescence microscopy (E). (D) ToF-SIMS image of an adjacent 
tissue section incubated with the liposomes but without the antibodies (negative control). (F) Optical image 
(bright-field) of the same tissue section and region as (E). D13-PC+ = liposomes, MC = maximum counts in one 
pixel, TC = total counts. Scale bar = 100 µm. Reprinted with permission from (Carlred et al. 2014). Copyright 
2014, American Chemical Society. 
 The aim of this study was not only to detect Aβ with ToF-SIMS, but also to image different 
lipids in parallel to Aβ. Since the liposomes were made of deuterated phospholipids, it was 
possible to image the native phospholipids in the surrounding tissue. Also, other lipids, such 
as cholesterol and sulfatides were successfully imaged in the vicinity of the Aβ deposits, 
revealing mostly complementary distribution patterns, although, some enrichment of 
sulfatides was observed close to some of the deposits (Fig. 13). 
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Figure 13 Simultaneous imaging of Aβ and lipids in an AD mouse brain tissue section using antibody-coupled 
liposomes and ToF-SIMS. ToF-SIMS images showing the distribution of (A) Aβ-bound liposomes (D13-
POPC+), (B) cholesterol (Chol-) and (C) sulfatide (Sulf-) ions. (D) Overlay image of liposomes (red), sulfatides 
(green) and cholesterol (blue). Scale bar = 50 µm. Reprinted with permission from (Carlred et al. 2014). 
Copyright 2014, American Chemical Society. 
However, when analyzing the spatial distribution of different biomolecules, and in particular 
lipids, it is of vital importance to make sure that the preparation protocol does not interfere 
with the sample integrity in some way. Several previous studies have shown that lipid 
migration might occur when raising the temperature of the sample (Sjövall et al. 2006), or 
when using fixatives or different kinds of rinsing buffers (C. Bich et al. 2013a; Malm et al. 
2009). Therefore, the effects of the preparation protocol used in this approach were carefully 
investigated, by first analyzing the untreated tissue section in frozen state (at −80°C), and then 
once again after the preparation of the tissue, at room temperature (RT). For this purpose, an 
easily recognizable area (corpus callosum) of the mouse brain was selected and analyzed both 
before and after antibody/liposome preparation (Fig. 14). The resulting ion images clearly 
show an enhanced yield of lipid ions of the treated sample, but no lateral redistribution could 
be observed for the selected lipids. The increased ion yield might be explained by a 
combination of the raised temperature during the preparation, and by changes in the chemical 
environment, since the rinsing buffer used in the protocol (ammonium formate) is known to 
remove salt from the surface, which otherwise is known to suppress the ionization probability. 
Also, the spectrum of the prepared tissue section did not contain any additional unexpected 
peaks, such as artifacts from the preparation (see supporting information in paper II). Thus, it 
was concluded that the preparation protocol used in this approach does not generate major 
modifications of the lateral lipid distributions. 
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Figure 14 ToF-SIMS ion images showing the distribution of phosphatidylcholine (PC+),  cholesterol (Chol+) 
and sulfatides (Sulf-) in the corpus callosum of an untreated mouse brain section, analyzed at −80°C (upper 
row), and in the same brain region after antibody/liposome preparation, analyzed at room temperature (RT) 
(lower row). mc = maximum counts in one pixel. Scale bar = 100 µm. Reprinted with permission from (Carlred 
et al. 2014). Copyright 2014, American Chemical Society. 
PAPER III - IMAGING OF AMYLOID-ΒETA IN ALZHEIMER’S DISEASE TRANSGENIC MOUSE 
BRAINS WITH TIME-OF-FLIGHT SECONDARY ION MASS SPECTROMETRY USING 
IMMUNOLIPOSOMES  
In this paper, the liposome approach for detection of specific molecules in tissue sections was 
developed further by using antibody-conjugated liposomes, so called immunoliposomes. The 
selected target molecule was again Aβ in AD mouse brains, in order to provide a proof-of-
principle of the method in relation to previously published results (paper II). By using 
different antibodies and conjugating each of these to liposomes with a unique lipid 
composition, this approach opens up for the possibility to detect many different targets at the 
same time, at sensitivities on the single-molecule level.  
The specificity of the immunoliposome binding to Aβ was first evaluated on a model surface, 
consisting of PLLgPEG-biotin, neutravidin and biotinylated Aβ, using QCM-D (Fig. 15). In 
this graph, the adsorption/binding of each component to the surface can be clearly observed 
by the shifts in frequency (blue) and dissipation (red). The addition of immunoliposomes ((iv) 
in Fig. 15B) is indicated by large shifts in both frequency and dissipation, which is typical for 
liposome adsorption and depends on their inherent viscoelastic properties (Höök et al. 2001). 
As a control, the immunoliposomes were also added to another model surface without Aβ on 
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the surface (dotted lines in Fig. 15B) and the results showed no binding of the 
immunoliposomes to the surface, demonstrating specific binding of the immunoliposomes to 
Aβ. 
 
Figure 15 (A) Schematic illustration of the binding of an immunoliposome to biotinylated Aβ on a model 
surface consisting of PLLgPEG-biotin and neutravidin. (B) QCM-D graph showing the shifts in frequency (blue) 
and dissipation (red) when each of the components of the model surface is added to the quartz crystal sensor 
surface; (i) PLLgPEG-biotin, (ii) neutravidin, (iii) biotinylated Aβ (Abeta) and (iv) immunoliposomes (6E10-
POPC). The dotted curves show adsorption of each component to a model surface where Aβ was omitted (no 
Abeta), as a control of nonspecific binding of the immunoliposomes to the surface. Reprinted with permission 
from (Carlred et al. 2016a). Copyright 2016, American Vacuum Society. 
The immunoliposomes were further applied to tissue sections and investigated with 
fluorescence microscopy and ToF-SIMS for detection of Aβ deposits in the mouse brain. As 
an additional control, adjacent tissue sections were also stained with conventional IHC (that 
is, using primary and secondary antibodies), to compare with the immunoliposome-stained 
tissue sections. An example of the acquired ToF-SIMS and fluorescence images is shown in 
figure 16, which shows an Aβ deposit in the cortical region of the mouse brain, revealed by 
immunoliposome binding for subsequent detection with ToF-SIMS (Fig. 16B) or fluorescence 
microscopy (Fig. 16C-D). Figure 16A shows the total ion signal in the same region of the 
tissue sample analyzed before any preparations (untreated), revealing some topographic 
effects in the Aβ-affected area. 
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Figure 16 Localization of Aβ deposits in an AD mouse brain section using immunoliposomes. (A-B) ToF-SIMS 
images showing (A) the total (+) ion image of the untreated tissue sample indicating some topographic features 
in the cortical region of the mouse brain. (B) ToF-SIMS high resolution ion image of the same tissue section and 
region as in (A) but after incubation with immunoliposomes, showing the immunoliposome-signal (D13-PC+) 
from the region outlined by the square in (A). (C-D) Fluorescence images of the same tissue sample as (A-B) 
visualizing the binding of immunoliposomes (red) to an Aβ deposit at (C) 10⨯ magnification (scale bar = 200 
µm) and (D) at 40⨯ magnification (scale bar = 50 µm). Cell nuclei are counterstained with DAPI (blue). 
Reprinted with permission from (Carlred et al. 2016a). Copyright 2016, American Vacuum Society. 
Using the immunoliposome approach, Aβ and surrounding molecules can be investigated at 
the same time. In this way, several lipids, such as phosphatidylcholine, cholesterol, sulfatides 
and palmitic acid, were detected in the vicinity of the Aβ deposit (Fig. 17). Most of these 
lipids showed a complementary distribution to the Aβ deposit, although the sulfatides and 
palmitic acid displayed some colocalization with Aβ (Fig. 17D-F). Since the palmitic acid is a 
component of the fatty acids included in liposomes (POPC), this colocalization might be an 
artifact from the immunoliposomes, whereas the presence of sulfatides, in combination with 
cholesterol, might be an indication of degenerative processes in the myelin sheaths (that 
surrounds the axons of the nerve cells). These processes are highly relevant for the generation 
of AD pathology and needs further attention. 
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Figure 17 (A-E) ToF-SIMS high resolution ion images of (A) Aβ-bound immunoliposomes (D13-PC+), (B) 
phosphatidylcholine (PC+), (C) cholesterol (Chol+), (D) sulfatides (Sulf-) and (E) palmitic acid (16:0). (F) 
Overlay image of liposomes (red), sulfatides (green) and cholesterol (blue). Scale bar = 20 µm. Reprinted with 
permission from (Carlred et al. 2016a). Copyright 2016, American Vacuum Society. 
As described in paper II, it is of vital importance to investigate possible effects of the 
preparation protocol on the sample integrity. Therefore, even though the sample preparation 
procedure is almost the same as in paper II, a tissue sample was analyzed with ToF-SIMS, 
before preparation (untreated, at room temperature) and then once again in the same region 
after incubation with the immunoliposomes. The results showed that the overall lipid 
distributions did not change considerably by the treatment. However, the secondary ion yield 
decreased significantly for almost all of the analyzed lipids (to ~15-25% of the untreated 
sample), except for the sulfatides, which increased with almost 160%. The effect was most 
prominent in the white matter of corpus callosum, where the cholesterol signal was 
significantly reduced and the sulfatides highly increased after liposome preparation, compared 
to the other brain regions. 
These results are in contrast to our previous findings, in paper II, where it was found that all 
lipid signals were increased by the sample preparation. However, an important difference 
between the two studies is that the previous compared the ion yields with a sample in frozen 
state (at −80°C), while in this study the untreated sample was analyzed at room temperature 
(freeze-dried), thus removing the temperature aspect between the treated and untreated 
sample. It is therefore possible that the increased ion yields that were observed in the previous 
study were mainly caused by the elevated temperature, which might induce lipid migration to 
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the surface (Sjövall et al. 2006). By preventing or reversing this migration with the 
preparations in this study, enrichment of specific lipids, such as cholesterol, on the sample 
surface can be prevented. This, in turn, enables for the detection of other lipids on the surface, 
such as the sulfatides, which otherwise might be suppressed by the presence of cholesterol. A 
similar finding was discovered in a study by Angerer et al., in which the treatment of the 
tissue section with trifluoroacetic acid (TFA) reduced the cholesterol accumulation on the 
surface but enhanced the yields of many other lipids (Angerer et al. 2015b). 
PAPER IV - PROBING CEREBRAL AMYLOID-ΒETA PATHOLOGY IN TRANSGENIC ALZHEIMER’S 
DISEASE (ARCSWE) MICE USING MALDI IMAGING MASS SPECTROMETRY 
In this paper, another IMS technique was used to investigate the Aβ composition and 
distribution in AD mouse brains. For this purpose, a MALDI-TOF IMS instrument was used, 
which offers the possibility to investigate the distribution of peptides and proteins in the 
tissue. A challenge with MALDI IMS is the sample preparation, which needs to be optimized 
for each type of sample and analyte (as described in section 3.5). Since Aβ is a small peptide 
with a molecular mass of ~4 kDa, CHCA was chosen as the matrix. Imaging in the range of 
m/z 2-20 kDa and with a lateral resolution of ~50 µm resulted in a broad distribution of peaks. 
In particular, several interesting peaks at m/z ~4000-4500 displayed a very distinct spotty 
distribution pattern in the mouse brain, especially in the hippocampus and cortex. The data 
was further analyzed using multivariate statistics to identify the peaks that were localized to 
these distinct spots. Not surprisingly, several of the observed peaks at m/z ~ 4000-4500, but 
also some peaks at m/z 6000-6500, were found to cluster together at these locations. In 
particular, several peaks corresponding to the m/z of different Aβ peptides, such as Aβ(1-37), 
Aβ(1-38) and Aβ(1-40), where the number denotes the number of amino acids in the peptide, 
were strongly associated to these spots. To verify that these peaks indeed correspond to Aβ 
peptides, IHC (using primary and secondary antibodies) was performed on the same tissue 
section after the MALDI analysis (Fig. 18). The resulting images showed clear colocalization 
patterns of Aβ, visualized with fluorescence microscopy (Fig. 18B-C), and the MALDI single 
ion images (Fig. 18D-F), demonstrating that these peaks corresponds to Aβ deposits. 
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Figure 18 Detection of Aβ deposits in an AD mouse brain using MALDI IMS. (A) Optical image of selected 
regions in the mouse brain, containing the hippocampus and cortex (ctx). CC = corpus callosum, DG = dentate 
gyrus, CA1, CA2 and CA3 = subregions in hippocampus, Th = thalamus, VL = left ventricle. Scale bar = 1 mm. 
(B-C) Fluorescence images of the same region as in (A), showing the distribution of Aβ, immunostained using 
primary (6E10) and secondary (goat anti-mouse Alexa Fluor 488) antibodies at low (B) and high (C) 
magnification of the region outlined by the square in (B). Scale bar = 200 µm. (D) MALDI single ion image of 
the peak corresponding to Aβ(1-40) peptides, showing the distribution of Aβ deposits in the same mouse brain as 
in (A-C). (E-F) Overlay image of the optical image in (A) and the ion image in (D), showing the location of Aβ 
in the cortical and hippocampal regions of the mouse brain at low (E) and high (F) magnification of the selected 
region outlined by the square in (E). Scale bar = 1 mm. Reprinted with permission from (Carlred et al. 2016b). 
Copyright 2016, John Wiley and Sons. 
To further investigate and validate the identity of the peaks at m/z 4000-4500, the deposits 
were analyzed using laser microdissection pressure catapulting (LMPC), which allows for 
collection of sample material from very specific areas in the tissue, followed by MALDI MS 
and MS/MS analysis. The resulting mass spectra clearly identified the previously observed 
peaks as Aβ(1-37), Aβ(1-38) and Aβ(1-40), as well as the Aβ(1-39) and Aβ(1-42) peptides 
(Fig. 19). 
 
Figure 19 Acquired mass spectrum from MALDI MS analysis of individual Aβ deposits, collected using LMPC. 
Reprinted with permission from (Carlred et al. 2016b). Copyright 2016, John Wiley and Sons. 
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The imaged Aβ deposits were further analyzed with statistical methods by collecting spectral 
data from these localized spots in different regions of the mouse brain, including the 
hippocampus, the somatosensory cortex and the somatomotor cortex, and comparing the 
spectra with data from adjacent regions (control) in the same tissue section, to reveal any 
region-specific Aβ composition. The results showed that several Aβ peptides, including Aβ(1-
38) and Aβ(1-40), were specifically localized to the deposits in all of the analyzed regions. 
Aβ(1-42), on the other hand, was only localized to the deposits in hippocampus and 
somatosensory cortex, whereas somatomotor cortex displayed a more dispersed distribution of 
this peptide. This finding indicates that this particular peptide, Aβ(1-42), has not been cleared 
from the nerve cells within this region yet, and might therefore be involved in intracellular 
neurodegenerative processes. However, more studies are needed to further evaluate this 
hypothesis; especially analysis on mouse brains at different ages would be helpful to reveal 
the Aβ generation and deposition. 
Furthermore, several unknown peaks, many of them in the range of m/z 6000-6500, were 
found to be associated to the Aβ deposits. One of these peaks, at m/z 6175, which was 
localized to the hippocampal Aβ deposits (Fig. 20), was putatively recognized as the 
microphage migration inhibitory factor (MIF), according to previous findings (Rahman et al. 
2011). To further investigate and validate the identity of this peak, IHC was performed, using 
antibodies directed to Aβ, MIF and also ionized calcium binding adaptor molecule 1 (Iba1), 
which is a marker for activated microglia. The resulting fluorescence images clearly showed 
colocalization of Aβ, MIF and Iba1 in the hippocampus. This thus indicates that the peak at 
m/z 6175 indeed corresponds to MIF, suggesting the involvement of activated inflammatory 
processes in AD pathology. 
 
Figure 20 (A) MALDI image of ion peak at m/z 6175 (red), putatively assigned to MIF, and (B) higher 
magnification of the hippocampal region showing the accumulation of MIF in the hippocampal region. The color 
palette in the figure indicates signal intensities from 0-100%. Scale bar = 500 µm. Reprinted with permission 
from (Carlred et al. 2016b). Copyright 2016, John Wiley and Sons. 
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PAPER V - LIPOSOME APPROACH FOR MULTIPLEXED QUANTIFICATION OF BIOMOLECULES AT 
SURFACES USING TIME-OF-FLIGHT SECONDARY ION MASS SPECTROMETRY 
In this paper, the liposome approach for detection of molecules on surfaces was developed 
further for detection and quantification of multiple targets on a model surface using 
immunoliposomes (as described in section 3.1 and in paper III). As a first step, the 
immunoliposomes, conjugated with antibiotin antibodies, were studied on model surfaces 
containing different concentrations PLLgPEG-biotin, to investigate specific binding and to 
determine the ability to quantify target concentrations on the surface. The immunoliposome 
binding was first investigated using QCM-D, on four model surfaces with different fractions 
PLLgPEG-biotin/PLLgPEG (0.08, 0.4, 2 and 10%). The results show a clear concentration 
dependent binding of the immunoliposomes to the surface (for further details, see Fig. 3 in 
paper V). The immunoliposome binding to different PLLgPEG-biotin (0-1%) surfaces was 
also investigated with fluorescence microscopy and ToF-SIMS, revealing a clear 
concentration dependent binding. Individual liposomes were clearly distinguishable in the 
images using both methods up to ~0.5% PLLgPEG-biotin, above which the liposomes were 
too close to be detected as individual entities. 
To be able to include multiple targets on the surface, another model surface was used, namely 
supported lipid bilayers (SLB). The SLBs were formed by fusion of liposomes adsorbed on 
the surface. By choosing the lipid content in the liposomes, different tags or recognition 
elements was included, which thus were presented on the surface of the SLB. The model 
surface was first studied by including biotinylated lipids in the SLB, to investigate specific 
binding of the antibiotin immunoliposomes to the surface. The second investigated target was 
the glycosphingolipid GM1, which is known to bind strongly with Cholera toxin subunit B 
(Chtx) (Merritt et al. 1994). Thus, GM1 was included in the SLB, while Chtx was conjugated 
to liposomes. To be able to distinguish between the antibiotin and the Chtx liposomes, 
different deuterated phospholipids were used (D4 and D13-POPC), as well as different 
fluorophores (ATTO 488 and Rhodamine), in the liposomes. The binding of antibiotin and 
Chtx liposomes to the two different targets was first investigated separately using QCM-D, 
which displayed good specific binding of both liposomes to the model surface. It was noted, 
however, that some nonspecific binding occurred to the surface as well, although it was 
considered to be small compared to the specific binding (see Fig. 4 in paper V). 
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The simultaneous binding of liposomes to two different targets was investigated further by 
detection with fluorescence microscopy and ToF-SIMS. For this purpose, the different targets 
were incorporated into the SLB by mixing POPC liposomes containing one of the targets 
(biotin or GM1, respectively) at different ratios (0-100%), while keeping the total 
concentration of targets on the surface to 0.01%. The target concentration was kept low to 
prevent saturation of liposome binding on the surface, and to be able to detect single 
liposomes. A schematic illustration of the liposome binding to the model surface is shown in 
figure 21A. The two different liposomes were successfully detected individually using both 
fluorescence microscopy (Fig. 21B) and ToF-SIMS (Fig. 21C). 
 
Figure 21 (A) Schematic illustration of the binding of antibiotin- (green) and Chtx- (red) conjugated liposomes 
to a SLB with biotin and GM1. (B) Fluorescence image (40⨯ magnification) showing the binding of both 
antibiotin liposomes (labeled with ATTO 488, green) and Chtx liposomes (labeled with Rhodamine, red), for 
multiplexed detection of biotin and GM1 in a SLB. Scale bar = 25 µm. (C) ToF-SIMS image at high spatial 
resolution (100⨯100 µm2), showing the distribution of antibiotin (detected by the D4-PC+ ions, green) and Chtx 
(detected by the D13-PC+ ions, red) liposomes, corresponding to biotin and GM1 on the surface. 
To be able to quantify the concentration of each liposome on the surface (corresponding to 
each target), eight different model surfaces with different ratios (0-100%) of each target 
(biotin or GM1, respectively) were used. The results show an increase in signal intensity with 
increasing concentration of each target on the surface (Fig. 22) and this trend was evident 
both with fluorescence microscopy (A) and ToF-SIMS (B). However, the Chtx liposomes 
(red) produced higher signal intensity, compared to the antibiotin-liposomes (green) at almost 
all model surfaces. This suggests that the Chtx liposomes bind more efficiently to the surface 
than the antibiotin liposomes. Although the reason for this difference is not known and needs 
further investigations, possible explanations include better binding of the Chtx liposomes to 
GM1 compared to the corresponding antibody binding to biotin, or more efficient exposure of 
the GM1 target on the surface compared to biotin. 
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Furthermore, the binding of each type of liposome was quite low in relation to the absolute 
target concentrations expected from the target mixing ratios in the SLBs. If all targets in the 
SLB were available for liposome binding, a fully covered liposome layer would be expected 
to form at target concentrations well below the 0.01% value used in this experiment. 
However, saturation of the liposome binding did not occur even when the target concentration 
was raised to 1%. The reason for the relatively low liposome concentrations at high target 
concentrations is not known and needs to be further investigated. 
 
Figure 22 Signal intensities from antibiotin (green) and Chtx liposomes (red) on surfaces containing different 
ratios (0-100%) biotin:GM1, detected with (A) fluorescence microscopy and (B) ToF-SIMS. The secondary ion 
yield was normalized to the total ion signal. 0:0 refers to the control surface with only POPC. The standard 
deviations are based on two samples (n=2).  
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5. DISCUSSION & OUTLOOK 
 
In this thesis, several approaches for detection of biomolecules on surfaces using IMS have 
been presented. First of all the liposome approach for detection of specific targets with ToF-
SIMS was presented, using the biotinylated liposomes for detection of different 
concentrations neutravidin on a model surface in paper I, and for detection of Aβ peptides in 
tissue sections in paper II. The development of protein-conjugated liposomes, for specific 
detection of multiple targets on the sample surface, was demonstrated for detection of Aβ in 
tissue sections in paper III, and for multiplexed detection of both biotin and GM1 in a SLB in 
paper V. The liposome approach presented in this thesis provides a new methodology for 
detection of proteins on surfaces using ToF-SIMS, since the liposomes are easily detected and 
distinguished in the mass spectrum using specific deuterated lipids, while the proteins 
themselves cannot be identified or distinguished due to fragmentation during the ion 
bombardment. An advantage of using ToF-SIMS for imaging of tissue sections is the parallel 
detection of several native lipids, without labeling or a priori knowledge. Most methods for 
investigation of lipids cannot provide the spatial distribution of the molecules, but using ToF-
SIMS imaging, a spatial resolution of <1 µm can be obtained.  
However, several obstacles need to be further investigated and protocols need to be further 
optimized to minimize nonspecific binding of the liposomes, which was observed in this work 
on the SLBs, but also in the tissue sections. Also, the binding efficiency between the 
recognition elements on the liposomes and the targets on the sample surface needs to be 
investigated for accurate quantification of different targets on the surfaces.  
Furthermore, more studies are needed to investigate lipid migration during the preparation of 
the tissue, especially with focus on cholesterol and sulfatides, to reveal their native 
distribution in relation to Aβ deposits. Solé-Domenèch et al. discovered small, cholesterol 
enriched inclusions close to Aβ deposits in AD mouse brains (Solé-Domènech et al. 2013). 
However, these inclusions have only been observed when analyzing the tissue in a frozen 
state. Since cholesterol has been shown to migrate to the surface when the temperature is 
elevated in vacuum, these studies must be done carefully for correct interpretation (Sjövall et 
al. 2006). Cholesterol accumulation on the surface is not desired, not only because it gives the 
wrong spatial information, but also because of its ability to suppress the ionization of other 
lipids in the surrounding tissue (Angerer et al. 2015b). 
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Using MALDI imaging, Aβ deposits could be detected in tissue sections without any labeling 
with liposomes, revealing the identity of several Aβ peptides in specific regions of the mouse 
brain. Further analysis of the mass spectrum revealed several other peptides/proteins 
associated with the deposits, where one could be putatively identified as the macrophage 
migration inhibitory factor (MIF), which is an important component in neuroinflammatory 
processes in the brain. However, due to extensive preparation of the tissue section prior to 
analysis, lipids cannot be detected at the same time as the proteins with MALDI. Instead, an 
adjacent tissue section can be analyzed for this purpose, by optimizing the preparation for 
detection of lipids instead of proteins. Furthermore, the spatial resolution is not as good in 
MALDI as with ToF-SIMS, thus limiting the field of view from subcellular structures to 
tissue regions. 
Thus, none of the imaging techniques discussed in this thesis provides a complete picture of 
all the molecules involved in the generation of AD. Instead, they are complementary, and by 
using several analysis methods on the same, or adjacent tissue sections, more information can 
be obtained about possible interactions and components in the disease progression. 
Moreover, for investigation of the generation of Aβ deposition in the brain, analysis at 
different stages of the disease is needed, which can be performed using mice sacrificed at 
different ages (Lord et al. 2006). However, in this way there will also always be individual 
fluctuations between the different tissue samples. But, using the method described above for 
MALDI imaging, this could reveal when the Aβ deposition starts to be apparent, and which 
Aβ peptides or regions that are first involved in the process. Also, other important molecules 
could be revealed, some may even be age-dependent, which opens up for the discovery of 
new biomarkers for disease development.  
ToF-SIMS imaging with liposomes directed to Aβ at earlier stages of AD might shed more 
light on the aberrant lipid regulation associated with Aβ deposition, such as cholesterol 
dysregulation or sulfatide depletion (Han 2010; Puglielli et al. 2003). Also, if the problems 
with nonspecific binding can be circumvented, detection of intracellular Aβ accumulation 
might be possible, in combination with the detection of aberrant Tau pathology, by directing 
other immunoliposomes to hyperphosphorylated Tau fibrils or neurofibrillary tangles. Also, 
the possibility to detect and image GM1 in the plasma membrane, using the developed Chtx 
liposomes (paper V), in combination with the liposomes directed to Aβ, offers an interesting 
approach for determination of the aggregation process of monomeric Aβ peptides into 
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deposits (Kakio et al. 2001), especially in younger animals at an earlier stage of the disease. 
Also, clinical samples from patients with AD would be interesting to investigate with ToF-
SIMS using the liposomes, for detection of other unknown biomolecules, such as lipids or 
metabolites, involved in the disease progression. 
There are thus many interesting approaches to continue the investigation of biological 
surfaces with IMS, which could play an important role for revealing complex molecular 
mechanisms involved in neurodegeneration and for the discovery of new biomarkers 
associated with AD. 
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6. CONCLUSIONS 
 
In this thesis, several methods for detection of lipids and proteins on biological surfaces have 
been investigated. Using ToF-SIMS imaging, in combination with antibody-coupled 
liposomes, it was possible to image the distribution of Aβ peptides in parallel with several 
lipids, such as cholesterol and sulfatides, in tissue sections from AD mouse brains. It was also 
possible to detect two different targets, the vitamin biotin and the glycosphingolipid GM1, 
respectively, at the same time in a SLB using the liposome approach. This method thus 
provides new opportunities to investigate interactions between lipids and proteins in 
biological samples. 
Using MALDI imaging, it was possible to investigate the spatial distribution and peptide 
composition of Aβ deposits in mouse brains. In this way, several different Aβ species were 
identified, in specific mouse brain regions. Also, other peptide species were discovered to 
colocalize with Aβ, of which one was identified as the macrophage migration inhibitory 
factor. This method opens up for the discovery of new biomolecules involved in the 
generation of AD and may thus give new insights into the disease mechanism as well as 
providing new potential biomarkers for disease progression. 
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